May 28, 2019
Northampton, UK – 28th May 2019 – HORIBA UK Ltd, Medical announces the go live of the first multi-site installation of its new HELO high throughput fully automated haematology platform within the Cardiff and Vale University Health Board. The new system is already delivering laboratory efficiencies across Cardiff in line with NHS requirements through the next generation haematology analysers installed at the University Hospital of Wales (UHW) and University Hospital, Llandough. Both sites are f...
May 20, 2019
Seralite®– FLC Serum granted registration by the Brazilian Health Regulatory Agency (ANVISA)
Abingdon Health is pleased to announce Seralite® – FLC Serum has been granted registration by the Brazilian Health Regulatory Agency (ANVISA)
Mar 29, 2019
The Leiden based biotechnology firm Idris Oncology is one of the three SME’s in Europe to receive human tissue through the Codex4SME’s consortium, in order to help them progress their diagnostic product towards clinical application.
Mar 27, 2019
New Yumizen GDDi 2 (D-Dimer) reagent kit for DVT and Pulmonary Embolism diagnosis
Mar 13, 2019
Study to show high accuracy of SNPfitR in predicting Alzheimer’s risk in both carriers and non-carriers of ApoE4
Feb 07, 2019
Crawley, UK – 07 February 2019 – Radiometer Limited’s AQT90 FLEX analysers have been used in a successful trial to asses D-dimer point-of-care testing (POCT) for suspected lower limb deep vein thrombosis (DVT). The editorial piece, published in Emergency Nurse , describes a reduction in patient waiting times of up to 75%.
Jan 31, 2019
Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden
Jan 29, 2019
FDA cleared POC hemoglobin analyzer to be sold across the USA by the market’s leading and most established healthcare distributor
Jan 24, 2019
Streck Cell-Free DNA BCT® CE blood collection tubes allow isolation of high-quality cell-free DNA (cfDNA) for use in a wide range of applications such as non-invasive prenatal testing (NIPT) and liquid biopsies.
Dec 12, 2018
QuantuMDx Group Limited and Molbio Diagnostics Private Limited have signed a memorandum of understanding (MoU) to explore opportunities for joint working in infectious disease diagnostics, with an initial focus on genotypic drug resistance testing for those infected with tuberculosis.